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Background and Purpose—Thrombus characteristics and collateral score are associated with functional outcome in patients 
with acute ischemic stroke. It has been suggested that they affect each other. The aim of this study is to evaluate the 
association between clot burden score, thrombus perviousness, and collateral score and to determine whether collateral 
score influences the association of thrombus characteristics with functional outcome.
Methods—Patients with baseline thin-slice noncontrast computed tomography and computed tomographic angiography 
images from the MR CLEAN trial (Multicenter Randomized Clinical Trial of Endovascular Treatment of Acute Ischemic 
Stroke in the Netherlands) were included (n=195). Collateral score and clot burden scores were determined on baseline 
computed tomographic angiography. Thrombus attenuation increase was determined by comparing thrombus density 
on noncontrast computed tomography and computed tomographic angiography using a semiautomated method. The 
association of collateral score with clot burden score and thrombus attenuation increase was evaluated with linear 
regression. Mediation and effect modification analyses were used to assess the influence of collateral score on the 
association of clot burden score and thrombus attenuation increase with functional outcome.
Results—A higher clot burden score (B=0.063; 95% confidence interval, 0.008–0.118) and a higher thrombus attenuation increase 
(B=0.014; 95% confidence interval, 0.003–0.026) were associated with higher collateral score. Collateral score mediated the 
association of clot burden score with functional outcome. The association between thrombus attenuation increase and functional 
outcome was modified by the collateral score, and this association was stronger in patients with moderate and good collaterals.
Conclusions—Patients with lower thrombus burden and higher thrombus perviousness scores had higher collateral score. 
The positive effect of thrombus perviousness on clinical outcome was only present in patients with moderate and high 
collateral scores.
Clinical Trial Registration—URL: http://www.trialregister.nl. Unique identifier: NTR1804 and URL: http://www.
controlled-trials.com Unique identifier: ISRCTN10888758.   
(Stroke. 2018;49:391-396. DOI: 10.1161/STROKEAHA.117.019509.)
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Recent trials demonstrated treatment benefit of endovas-cular treatment (EVT) in patients with acute ischemic 
stroke caused by a proximal intracranial large vessel occlu-
sion of the anterior circulation.1–5 Various imaging measures 
were associated with good outcome.6,7 Among these markers, 
collateral filling and thrombus characteristics are strongly 
associated with functional outcome.8–10
The collateral circulation consists of a network of vas-
cular anastomoses that potentially mitigate the effect of a 
blocked artery.11 Multiple studies have suggested that good 
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collateral circulation protects cortical areas and maintains 
penumbra, leading to improved outcome after EVT.12–15 
Further, treatment benefit of EVT in patients with absent or 
poor collateral filling of middle cerebral artery branches is 
still questionable.8,16
In addition to the collateral circulation, different thrombus 
properties may also have clinical implications.17 Thrombus 
permeability may allow oxygen and nutrients to reach tissue 
distal to the occlusion.18,19 It has been associated with func-
tional outcome, final infarct volume, and recanalization rate, 
especially after intravenous thrombolysis.9,20 Clot burden, 
length, and location were also associated with clinical out-
come.10,21 Further, thrombus attenuation (ie, the hyperdense 
artery sign) has been associated with poor outcome and lower 
recanalization rates after intravenous tPA (tissue-type plas-
minogen activator).22
It has been suggested that collateral circulation and throm-
bus characteristics are related.23 For example, thrombus bur-
den and location are thought to be associated with the extent 
of the collateral circulation.24,25 However, the association 
between collateral circulation and thrombus characteristics is 
still poorly understood. This study aims to investigate whether 
there is an association between thrombus characteristics and 
collateral circulation and whether the association between 
thrombus characteristics and functional outcome is modified 
or mediated by collateral circulation.
Methods
Patient Selection
The MR CLEAN trial (Multicenter Randomized Clinical Trial 
of Endovascular Treatment of Acute Ischemic Stroke in the 
Netherlands) was a multicenter prospective randomized trial com-
paring EVT in addition to usual care (intervention group) versus 
usual care only (control group) in patients with acute ischemic 
stroke caused by a proximal intracranial large vessel occlusion of 
the anterior circulation. Eligible patients had distal intracranial 
carotid artery, middle cerebral artery (M1 or M2), or anterior cere-
bral artery (A1 or A2) occlusions. MR CLEAN did not use clot 
burden score, collateral score, or thrombus attenuation increase as 
imaging selection criteria.1 Patients from the MR CLEAN database 
were retrospectively analyzed and included if thin-slice (≤2.5 mm) 
baseline noncontrast computed tomography (NCCT) and computed 
tomographic angiography (CTA) were available. Exclusion criteria 
were excessive noise, presence of motion artifacts, and incomplete 
visualization of the intracranial vasculature.
The MR CLEAN trial was approved by a central medical eth-
ics committee and the research boards of all participating centers. 
Written informed consent was acquired from all patients or legal 
representatives. Because of the sensitive nature of the data collected 
for this study, requests to access the data set may be sent to the MR 
CLEAN executive committee (https://www.mrclean-trial.org/).
Collateral Score and Thrombus 
Characteristics Assessment
Clot burden was determined according to the clot burden score as 
described by Puetz et al.26 A score of 10 on the clot burden score indi-
cates that no occlusion is present. Two points are deducted for lack of 
contrast opacification in the supraclinoid internal carotid artery and 
both the proximal and distal M1 segment. One point is deducted for 
lack of opacification in the M2 branches, the A1 segment, or the infra-
clinoid internal carotid artery. Two experienced neuroradiologists 
from the MR CLEAN imaging committee evaluated the CTA data. 
In case of discrepancies between the 2 observers, a third observer 
performed a consensus reading. All readers were blinded to clinical 
findings, except symptom side.
Thrombus segmentation was performed using an adapted semiau-
tomated method.27,28 This method operated on a custom-developed 
Mevislab interface in which NCCT and CTA were coregistered and 
simultaneously displayed. Thrombus segmentation on CTA images 
was performed in 3 steps: (1) segmentation of the contralateral vas-
culature by a trained observer (E.M.M.S.); (2) segmentation of the 
occluded artery using mirror symmetry; (3) thrombus segmentation 
using intensity-based region growing. The CTA-based thrombus 
mask was automatically projected on NCCT. Thrombus attenuation 
increase was defined by the difference between the CTA and NCCT 
thrombus attenuation distribution.
Collaterals and clot burden were determined on baseline CTA. The 
collateral score grades distal arteries filling with a 4-point scale with 0 
constituting absent collaterals (0% filling of the occluded territory), 1 
for poor collaterals (>0% and ≤50% filling of the occluded territory), 
2 for moderate collaterals (>50% and <100% filling of the occluded 
territory), and 3 for good collaterals (100% filling of the occluded 
territory).25
Statistical Analysis
Functional outcome was assessed using the modified Rankin Scale 
(mRS) score at 3 months. On this scale, a score of 0 corresponds 
to no symptoms and a score of 6 to death. Ordinal regression anal-
ysis was used to evaluate the associations of clot burden score, 
thrombus attenuation increase, and collateral score with functional 
outcome (mRS score). The association between thrombus charac-
teristics (clot burden score and thrombus attenuation increase) and 
collateral score was assessed using linear regression. Complete 
recanalization was defined as a modified arterial occlusive lesion 
score of 3.
Mediation analyses29,30 were used to assess whether the associa-
tion between thrombus characteristics (clot burden score or thrombus 
attenuation increase) and functional outcome could be secondary to 
the influence of these thrombus characteristics on collateral circula-
tion. Mediation analysis seeks to explain a relation between an inde-
pendent variable (thrombus characteristics) and a dependent variable 
(mRS score) via the inclusion of a third hypothetical variable (col-
lateral score). To assess mediation, the first step is to show that the 
independent variable (X) is associated with outcome (Y). The second 
step is to establish an association between X and the mediator (M). The 
third step is to demonstrate the association between M and Y, using 
X and M as independent variables (Figure 1). The mediation model 
proposes that X influences M, which in turn influences Y by an indirect 
Figure 1. The steps of mediation analysis; X, independent vari-
able; M, mediator variable; Y, outcome variable; a, regression 
coefficient of the association between X and M; b, regression 
coefficient of the association between M and Y, using X and M as 
independent variables; c, regression coefficient of the associa-
tion between X and Y; c′: regression coefficient of the association 
between X and Y, using X and M as independent variables.
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pathway, rather than a direct causal relationship between X and Y. The 
unstandardized regression coefficients were analyzed. To demonstrate 
mediation, the coefficient describing the association of X with Y (c) 
must be greater than the regression coefficient describing the associa-
tion of X with Y after controlling for M (c′). The extent of mediation 
is estimated by subtracting the coefficients (c−c′). The Sobel test is 
used to evaluate the significance of the mediation (indirect) effect. An 
assumption for mediation analysis is that X and M do not interact in the 
association to Y.31 To assess effect modification, a multiplicative inter-
action term (X*M) was included in the analysis. If there was evidence 
of significant interaction, the association of X and Y in subgroups of 
M (ie, collateral grade) was further explored. Statistical analyses were 
performed using SPSS v22.0 (IBM Corp, Armonk, NY).
Results
Of the 500 patients from the MR CLEAN trial, 227 had thin-
slice (≤2.5 mm) baseline NCCT and CTA. Thirty-two patients 
were subsequently excluded for excessive noise (n=8), pres-
ence of motion artefacts (n=21), or incomplete visualization 
of the intracranial arterial tree (n=3). A total of 195 patients 
were included in this study. One hundred seventy-two (88%) 
received intravenous alteplase and 78 (40%) were treated 
with EVT. Evaluations with χ2 tests indicated that there was 
no significant difference in frequency of EVT (P=0.19) and 
intravenous alteplase (P=0.36) per collateral grades. Seventy-
nine (40%) patients had complete recanalization. Baseline 
characteristics are displayed in Table 1.
Table 1. Patients Characteristics
Patients Characteristics
CS 0 (n=11) CS 1 (n=57) CS 2 (n=74) CS 3 (n=53)
Age, median (IQR), y 69 (57–81) 67(56–78) 66(56–77) 63(57–70)
NIHSS score, median (IQR) 21 (16–26) 16(11–21) 14(7–21) 17(8–26)
Systolic blood pressure, mean mm HG (SD) 150 (9.8) 139 (2.8) 142 (2.8) 146 (3.3)
Onset to randomization in min, median (IQR) 217 (161–273) 184(129–239) 184.5(131–237) 188(132–244)
Clot burden score, median (IQR) 5 (4–6) 5(4–7) 6(5–7) 6(4–8)
Thrombus attenuation increase, mean (SD) 1.9 (1.9) 6.9 (1.5) 8.2 (1.2) 10.1 (1.4)
Male sex, n(%) 7 (63.4) 36 (63.2) 44 (59.5) 32 (60.4)
Symptomatic hemisphere, left, n (%) 7 (63.4) 26 (45.6) 45 (60.8) 32 (60.4)
Atrial fibrillation, n (%) 4 (36.4) 16 (28.1) 21 (28.4) 12 (22.6)
History of ischemic stroke, n (%) 0 (0) 10 (17.5) 5 (6.8) 6 (11.3)
History of myocardial infarction, n (%) 1 (9.1) 10 (17.5) 16 (21.6) 6 (11.3)
History of peripheral artery disease, n (%) 0 (0.0) 4 (7.0) 5 (6.8) 4 (7.5)
History of diabetes mellitus, n (%) 2 (18.2) 8 (14.0) 10 (13.5) 6 (11.3)
History of smoking, n (%) 5 (45.5) 14 (24.6) 19 (25.7) 13 (24.5)
Current statin use, n (%) 3 (27.3) 23 (40.4) 17 (23.0) 17 (32.1)
Current anticoagulant use, n (%) 1 (9.1) 7 (12.3) 5 (6.8) 6 (11.3)
Current antiplatelet use, n (%) 4 (36.4) 18 (31.6) 26 (35.1) 12 (22.6)
Prestroke mRS score, n (%)
  0 9 (81.8) 41 (71.9) 57 (77.0) 40 (75.5)
  1 2 (18.2) 9 (15.8) 11 (14.9) 8 (15.1)
  ≥2 0 (0.0) 7 (12.3) 6 (8.1) 4 (7.5)
Treatment with IV alteplase, n (%) 9 (81.8) 48 (84.2) 69 (93.2) 46 (86.8)
Treatment with endovascular therapy, n (%) 1 (9.1) 24 (42.1) 32 (43.2) 21 (39.6)
CS indicates collateral score; EVT, endovascular therapy; IQR, interquartile range; mRS, modified Rankin Scale; and NIHSS, National Institutes of 
Health Stroke Scale.
Figure 2. The mediation analysis by collateral score of the asso-
ciation between clot burden score and modified Rankin Scale 
(mRS) score; a, regression coefficient of the association between 
clot burden score (CBS) and collateral score (CS); b, regression 
coefficient of the association between CS and mRS score, using 
CS and CBS as independent variables; c, regression coefficient 
of the association between CBS and mRS score; c′, regression 
coefficient of the association between CBS and mRS score, 
using CS and CBS as independent variables.
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Association Between Thrombus Characteristics  
and Collateral Score
Higher clot burden score was significantly associated with a 
higher collateral score (B=0.063; 95% confidence interval, 
0.008–0.12), indicating that patients with smaller clot burden 
usually have higher collateral scores. Thrombus attenuation 
increase was also significantly associated with collateral score 
(B=0.014; 95% confidence interval, 0.003–0.026). This indi-
cates that patients with a pervious thrombus more frequently 
have higher collateral scores.
Mediation by Collateral Score of the Association 
Between Clot Burden Score and mRS Score
There was no significant interaction between collateral 
score and clot burden score in their association with func-
tional outcome (P value for the interaction=0.86). Collateral 
score mediated the association between clot burden score 
and mRS score and the significance of the indirect path-
way (Sobel test) was 0.04 (Figure 2). After adding collateral 
score as an independent variable, the regression coefficient 
of clot burden score with mRS score reduced from 0.10 to 
0.069 (Table 2).
Modification of the Association Between  
Thrombus Attenuation Increase and mRS  
Score by Collateral Score
Collateral score significantly modifies the relation between 
thrombus attenuation increase and mRS score (P value for 
the interaction of 0.021). For patients with good and moderate 
collaterals, increases in thrombus attenuation increase leads to 
higher probability of lower mRS score (Figure 3). This rela-
tion between thrombus attenuation increase and mRS score 
could not be established in patients with collateral score <2 
(Table 3). Given the significant interaction between thrombus 
attenuation increase and collateral score, the mediation analy-
sis has not been performed.
Discussion
In our population, higher collateral scores were associated 
with lower clot burden and greater thrombus perviousness. 
We have shown that the association between thrombus pervi-
ousness and functional outcome varies for different collateral 
scores. The relation between thrombus attenuation increase 
and functional outcome was only established for patients with 
good and moderate collaterals.
Only few studies assessed the relation between collateral 
score and thrombus characteristics and the mediation of col-
lateral score on the association of thrombus characteristics 
with outcome. Qazi et al23 found an association between col-
laterals and thrombus length in which patients with poor base-
line collaterals had longer clots. Our study is in agreement 
with 2 previous studies in which poorer collaterals in patients 
with more proximal thrombus29 and an association between 
collateral score and clot burden score have been described.25
Higher clot burden score indicates smaller thrombus. 
Patients with a smaller clot burden are more likely to have 
patent anterior cerebral arteries and posterior communicating 
Table 2. Mediation Analysis by Collateral Score on the 
Association of Clot Burden Score With Functional Outcome 
(mRS Score)
Effect B SD OR CI 95% P Value
a 0.063 0.028 … … … 0.025
b 0.771 0.1556 2.162 1.593 2.933 0.000
c 0.104 0.0569 1.110 0.993 1.241 0.067
c′ 0.069 0.0577 1.071 0.957 1.199 0.234
B is unstandardized regression coefficient; a is regression coefficient of the 
association between clot burden score and collateral score; b is regression 
coefficient of the association between collateral score and mRS score, using 
collateral score and clot burden score as independent variables; c is regression 
coefficient of the association between clot burden score and mRS score; c′ is 
regression coefficient of the association between clot burden score and mRS 
score, using collateral score and clot burden score as independent variables. 
CI 95% indicates 95% confidence interval; mRS, modified Rankin Scale; and 
OR, odds ratio.
Figure 3. Linear plot demonstrating the probability of good functional outcome for different values of collateral score and thrombus atten-
uation increase. Effect modification (or moderation) analysis demonstrating that the association between thrombus attenuation increase 
and good outcome is different depending on the collateral score. The probability was calculated using the ordinal regression equation 
with the multiplicative interaction term. mRS indicates modified Rankin Scale.
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arteries (Willisian routes), leading to increased pial collateral 
flow. The enhanced pial collateral improves the collateral score 
and subsequently increases the odds of favorable outcome.8 
Conversely, higher collateral score also results in higher clot 
burden score through retrograde filling of distal branches in 
proximal occlusions. The significant mediation by collateral 
score of the association of clot burden score and mRS score 
found in this study supports the thesis that enhancing col-
lateral circulation at least partially underlies the association 
between clot burden score and functional outcome. However, 
the value of the coefficient implies limited explanation of the 
functional outcome by the clot burden score.
Higher collateral scores are also associated with more pervi-
ous thrombi. Thrombus perviousness may allow flow through 
the thrombus, resulting in anterograde filling of the arteries 
distal to the occlusion. The presence of residual flow through 
the thrombus is associated with increased recanalization rate 
after intravenous thrombolysis.30 This effect on treatment suc-
cess might explain the strong association between thrombus 
attenuation increase and improved functional outcome. Only 
in patients with good and moderate collaterals, however, are 
increases in thrombus attenuation strongly associated with 
functional outcome. This finding corroborates the importance 
of good collateral circulation on anterograde flow. Other pos-
sible reason is that poor and absent collaterals are so strongly 
associated with poor functional outcome that variations in 
thrombus attenuation are not relevant.
Limitations
The automated segmentation method to measure thrombus per-
viousness is a strength in our study. It reduces user-dependent 
measurement variations and improves reproducibility. However, 
our study also has several limitations. First, this study has a 
relatively modest sample size and is an exploratory post hoc 
analysis. It is of great interest to study whether the mediation 
and effect modification differ between treatment arms. This was 
beyond the scope of this study. The small number of patients, 
in particular with collateral score of 0, seems unbalanced for 
prognostic factors (age, National Institutes of Health Stroke 
Scale score, time to randomization, and treatment allocation) 
and precluded independent analysis of each treatment arm of 
MR CLEAN. The lack of adjustment for possible confounders 
because of the small number of patients with collateral score 
0 might also have influenced our results. Such a study could 
be performed in future pooled analysis. Further, single-phase 
CTA has a major impact on collateral grading status. Previous 
studies have shown that the lack of temporal information in a 
CTA causes an underestimation of collateral score when com-
pared with multiphase CTA, particularly in early-phase acquisi-
tions.31 The presence of anterograde flow through the thrombus 
was implied by thrombus attenuation increase; however, direc-
tional flow information can be derived by time-density curves 
on dynamic imaging and by attenuation coefficient gradients 
on single-phase CTA.32 The lack of backflow from collateral 
circulation can also underestimate clot burden score.33,34 Single-
phase CTA acquisition may also underestimate the maximum 
attenuation increase of the thrombus. However, a recent study 
demonstrated that arterial-phase CTA is stronger associated 
with outcome than any other phase or combination of phases.35 
Also, tube voltage can change the Hounsfield unit of the throm-
bus.36 The mediation analysis harbors potential limitations by 
inferring causal relations to observational data. Last, to assess 
the association between clot burden score and collateral score, 
we used both variables as if they are continuous.
Conclusions
In our population, collateral scores are associated with throm-
bus characteristics: Patients with higher collateral scores had 
lower thrombus burden and more pervious thrombi. The asso-
ciation between clot burden score and mRS score seems to 
be partially explained by lower clot burden score leading to 
higher collateral score. There is also an important influence of 
the collateral score on the association of thrombus attenuation 
increase with functional outcome.
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